ISDA

Deposition Date 2013-06-05

Release Date 2013-07-24

Last Version Date 2023-12-20

Entry Detail

PDB ID:

4BRX

Keywords:

TRANSFERASE

Title:

Focal Adhesion Kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor

Biological Source:

Source Organism:

GALLUS GALLUS (Taxon ID: 9031)

Host Organism:

TRICHOPLUSIA NI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.05 Å

R-Value Free:

0.23

R-Value Work:

0.19

R-Value Observed:

0.19

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:FOCAL ADHESION KINASE 1
Gene (Uniprot):PTK2
Chain IDs:A
Chain Length:276
Number of Molecules:1
Biological Source:GALLUS GALLUS

UniProt ID:Q00944 Pfam ID:PF07714 EC:2.7.10.2

Primary Citation

Synthesis of Novel Diarylamino-1,3,5-Triazine Derivatives as Fak Inhibitors with Anti-Angiogenic Activity.

Dao, P, Jarray, R, Le Coq, J, Lietha, D, Loukaci, A, Lepelletier, Y, Hadj-Slimane, R, Garbay, C, Raynaud, F, Chen, H.Show

Bioorg.Med.Chem.Lett. 23 4552 ? (2013)

PMID: 23845217 DOI: 10.1016/J.BMCL.2013.06.038

Abstact

We report herein the synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK (focal adhesion kinase) inhibitors and the evaluation of their anti-angiogenic activity on HUVEC cells. Generally, the effects of these compounds on endothelial cells could be correlated with their kinase inhibitory activity. The most efficient compounds displayed inhibition of viability against HUVEC cells in the micromolar range, as observed with TAE-226, which was designed by Novartis Pharma AG. X-ray crystallographic analysis of the co-crystal structure for compound 34 revealed that the mode of interaction with the FAK kinase domain is highly similar to that observed in the complex of TAE-226.

Legend

Protein

Chemical

Disease

Primary Citation of related structures